YPSOMED AG

Ypsomed AG is a Swiss-based leading developer and manufacturer of self-injection systems for liquid medications, with over 40 years of innovation in drug delivery technology. The company specializes in customized injection platforms for pharmaceutical and biotech partners, including disposable pens, autoinjectors (such as YpsoMate), and wearable on-body devices. Ypsomed operates a global manufacturing network with facilities in Burgdorf, Schwerin, Changzhou, and Solothurn, employing over 2,000 people. The company provides comprehensive services spanning device development, clinical trial support (Clear-to-Clinic program), human factors engineering, and digital health integration. Products are designed for subcutaneous self-administration of therapeutics across chronic disease categories including diabetes, autoimmune conditions, and specialty biologics. Ypsomed emphasizes sustainable manufacturing practices, having achieved LEED Platinum certification at its Changzhou facility, and maintains 100% renewable energy sourcing for operations.